Preclinical In Vivo Imaging in Systemic Tumor Models

Champions has integrated preclinical in vivo imaging into its cutting-edge research platforms to enable researchers to better understand oncology disease progression in systemic tumor models. 

Using bioluminescence imaging (BLI) offers the ability to non-invasively measure qualitatively and quantitatively the tumor burden within each animal in real-time throughout your in-life study. 

Champions has optimized several luciferase-tagged tumor models within the preclinical in vivo imaging platform that can be used to detect and monitor tumor growth in real-time, in order to evaluate therapeutic efficacy.